Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis

Pérez-Torres Lobato, María Rosario; Mejías Trueba, Marta; Rodríguez Ramallo, Héctor; Álvarez del Vayo Benito, Concepción; Iglesias Aguilar, Maria del Carmen; Gaboli, Mirella.
Arch. bronconeumol. (Ed. impr.) ; 57(10): 662-664, Oct. 2021. tab
Artículo en Inglés | IBECS (España) | ID: ibc-212184

Documentos relacionados

  1. Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
  2. Spray Pattern and Plume Geometry Testing and Methodology: An IPAC-RS Working Group Overview.
  3. Good Cascade Impactor Practice (GCIP) and considerations for "in-use" specifications.
  4. RiceSorb<sup>®</sup> as Talcum Substitute for Loose Face Powders: Formulation and Characterization.
  5. Quantifying Agglomerate-to-Wall Impaction in Dry Powder Inhalers.
  6. Development of nitric oxide generators to produce high-dose nitric oxide for inhalation therapy.
  7. Role of Induction of Sputum in Various Respir atory Diseases of Infective Etiology.
  8. Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS).
  9. Characterization of Membrane-Type Dissolution Profiles of Clinically Available Orally Inhaled Products Using a Weibull Fit and a Mechanistic Model.
  10. Differences in the Response to High-Dose Inhaled Nitric Oxide in Self-identified Black and White Individuals: A <i>Post Hoc</i> Analysis of the NOSARSCOVID Randomized Clinical Trial.